Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com
  • Permalink Gallery

    ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions, one of the nation’s leading providers of pharmacy cost containment services in the Workers Compensation industry, will feature the 2018 Renewal of its $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC in Las Vegas Nevada on December 6th, 2017 at BOOTH 2615.

Our program provides Workers Comp payers a guarantee on the life expectancy savings achieved via our “industry unique” pharmacy intervention process.  We assure our clients a $1 Million Dollar Savings per 10 Case Referral as part of a Pilot Program with the Company.  […]

By |December 4th, 2017|Pharmacotherapy Review|Comments Off on ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

Opioid Rescue Therapy, Not Just A Quick Fix…

91 Americans lose their lives every day to opioid overdose, according to the Centers for Disease Control and Prevention (CDC).  That is over 33,000 Americans each year, and the rate is only rising, actually having quadrupled since 1999.  It is now accurately categorized as an Epidemic and, appropriately, stringent private and public institutional changes are being implemented to minimize the likelihood of future abuse.  This includes limited pill counts, prescription drug monitoring platforms, closed formularies, etc.  These improvements reduce the likelihood of future dependency, but what about those already […]

By |November 13th, 2017|Drug Utilization Review, Medical Cost Containment|Comments Off on Opioid Rescue Therapy, Not Just A Quick Fix…

NCIGF May 3-4, 2018

ANS Solutions will be exhibiting here :
NCIGF

May 3-4, 2018
Westin – Alexandria, VA

By |April 24th, 2017|ANS News & Events|Comments Off on NCIGF May 3-4, 2018

CMSA June 19-23, 2018

ANS Solutions will be attending:
CMSA
June 19-23, 2018 
McCormick Place – Chicago, IL

By |April 23rd, 2017|ANS News & Events|Comments Off on CMSA June 19-23, 2018

AASCIF July 22-25, 2018

ANS Solutions will be exhibiting here :

AASCIF
July 22-25, 2018
JW Marriott Minneapolis Mall of America – Minneapolis/St. Paul, MN

By |April 21st, 2017|ANS News & Events|Comments Off on AASCIF July 22-25, 2018

FL WC Conference (aka WCI) August 19-22, 2018

ANS Solutions will be attending: 
FL WC Conference (aka WCI)

August 19-22, 2018
Orlando World Center Marriott – Orlando, FL

By |April 19th, 2017|ANS News & Events|Comments Off on FL WC Conference (aka WCI) August 19-22, 2018

CWC & Risk Conference September 4-7, 2018

Visit ANS Solutions in Booth M20
CWC & Risk Conference

September 4-7, 2018 
Monarch Beach Resort – Dana Point, CA

By |April 18th, 2017|ANS News & Events|Comments Off on CWC & Risk Conference September 4-7, 2018

National WC & Disability Conference December 4-7, 2018

ANS Solutions will be exhibiting here :
National WC & Disability Conference

December 4-7, 2018
Mandalay Bay – Las Vegas, NV

By |April 17th, 2017|ANS News & Events|Comments Off on National WC & Disability Conference December 4-7, 2018

The Impact of Workers’ Compensation Compounding

As custom-made compound prescriptions concoctions continue to rack-up higher workers’ compensation costs, insurers are scrambling to find alternatives and employers are looking for relief from equally inflated premiums. With little to no evidence as to the efficacy of such creations, many states have implemented treatment guidelines directing doctors to more evidentiary-based, easily reimbursable options. Despite guidelines and formularies however, loopholes in coverage continue to allow providers to sell millions of dollars of compounds, with many companies submitting inflated reimbursement bills in their attempts to get paid.

A Growing Issue in […]

By |December 15th, 2016|Drug Utilization Review, Workers Compensation Industry|Comments Off on The Impact of Workers’ Compensation Compounding
  • Permalink Gallery

    New FDA Warning: Avoid Prescribing Opioids & Benzos Together

New FDA Warning: Avoid Prescribing Opioids & Benzos Together

In a recent announcement by the FDA, boxed warning labels will now be required to advise against the utilization of prescription opioid pain medicines alongside benzodiazepines unless no other adequate alternative treatment method exists. Warnings about the risks of combining these two classes of drugs are nothing new. Already required on drug warning labels, additional black box warnings are an effort by the FDA to reach out to those who may have “missed the message.”

Classified as Central Nervous System (CNS) depressants, each drug alone can trigger side effects such […]

By |November 21st, 2016|Pharmaceutical Industry, Pharmacotherapy Review|Comments Off on New FDA Warning: Avoid Prescribing Opioids & Benzos Together